Fisher Andrew
Insider CIK 2014301 · VRNA General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VRNA Verona Pharma plc | M Exercise deriv | 2025-10-07 | 2025-10-08 | 146,168 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-10-07 | 2025-10-08 | 167,056 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | A Award deriv | 2025-10-07 | 2025-10-08 | 618,760 | — | $0 | 618,760 | SEC↗ |
| VRNA Verona Pharma plc | D To issuer deriv | 2025-10-07 | 2025-10-08 | 2,240,000 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-10-07 | 2025-10-08 | 618,760 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | D To issuer | 2025-10-07 | 2025-10-08 | 931,984 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | D To issuer | 2025-10-07 | 2025-10-08 | 417,903 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2025-10-07 | 2025-10-08 | 931,984 | — | $0 | 931,984 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-08-01 | 2025-08-05 | 20,888 | — | $0 | 146,168 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2025-08-01 | 2025-08-05 | 9,584 | $13.14 | $125.9K | 417,903 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2025-08-01 | 2025-08-05 | 20,888 | — | $0 | 427,487 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2025-07-08 | 2025-07-09 | 39,464 | $11.44 | $451.5K | 406,599 | SEC↗ |
| VRNA Verona Pharma plc | A Award deriv | 2025-07-07 | 2025-07-09 | 253,120 | — | $0 | 253,120 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-07-07 | 2025-07-09 | 86,064 | — | $0 | 167,056 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2025-07-07 | 2025-07-09 | 86,064 | — | $0 | 446,063 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-06-16 | 2025-06-18 | 80,000 | — | $0 | 2,240,000 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2025-06-16 | 2025-06-18 | 80,000 | $11.53 | $922.4K | 359,999 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2025-06-16 | 2025-06-18 | 80,000 | $2.01 | $160.8K | 439,999 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-05-15 | 2025-05-16 | 80,000 | — | $0 | 2,320,000 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-05-15 | 2025-06-18 | 80,000 | — | $0 | 2,320,000 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2025-05-15 | 2025-05-16 | 80,000 | $8.57 | $685.6K | 359,999 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2025-05-15 | 2025-05-16 | 80,000 | $2.11 | $168.8K | 439,999 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2025-05-15 | 2025-06-18 | 80,000 | $2.01 | $160.8K | 439,999 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-04-29 | 2025-05-01 | 86,064 | — | $0 | 167,056 | SEC↗ |
| VRNA Verona Pharma plc | A Award deriv | 2025-04-29 | 2025-05-01 | 253,120 | — | $0 | 253,120 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2025-04-29 | 2025-05-01 | 26,072 | $8.98 | $234.1K | 359,993 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2025-04-29 | 2025-05-01 | 86,064 | — | $0 | 386,065 | SEC↗ |
| VRNA Verona Pharma plc | G Gift | 2025-03-19 | 2025-05-01 | 1 | — | $0 | 300,001 | SEC↗ |
| VRNA Verona Pharma plc | A Award | 2024-10-30 | 2024-11-01 | 300,000 | — | $0 | 300,000 | SEC↗ |
| VRNA Verona Pharma plc | A Award deriv | 2024-04-01 | 2024-04-02 | 2,400,000 | — | $0 | 2,400,000 | SEC↗ |